To study fibrin incorporation into thrombi at different wall shear rates, a new method to study fibrin deposition on extracellular matrixes underlying stimulated endothelial cells under flow conditions was developed. For this method, we used fibrinogen labeled with peroxidase (Fg-PO). Fg-PO was fully exchangeable for Fg in the clotting assays tested, and PO activity was bound to fibrin-specific fragments. Fg-PO containing fibrin could be stained for microscopic studies with 3 r 3'-diaminobenzidine and could be quantified by oxidation of phenylenediamine. The absorbance values at 492 nm were converted to fibrin quantities via a standard curve. To study fibrin deposition, Fg-PO was added in trace amounts to whole blood anticoagulated with low-molecularweight heparin, and perfusion studies were performed over endothelial cell matrixes containing tissue factor. In parallel perfusion studies, '"i-labeled Fg was added in trace amounts to whole blood instead of Fg-PO. Both quantitative methods demonstrated decreased fibrin deposition after perfusions at 1,300 sec" 1 compared with fibrin deposition after perfusions at 300 sec"', while fibrinopeptide A generation was independent of the wall shear rate. The decrease in fibrin deposition at 1,300 sec' 1 was accompanied by the appearance of fibrin monomers in the perfusate. This suggested that the decrease in fibrin incorporation at 1,300 sec" 1 was due to the unpaired polymerization of fibrin monomers. This impairment was probably due to a decrease in local fibrin monomer concentration as a result of the increased removal of monomers from the surface at 1,300 sec" Fibrin accounts for most of the mass of thrombi found in large veins; such thrombi mainly consist of fibrin and red blood cells. 6 -7 In major epicardial coronary vessels and arterioles, the amount of fibrin incorporated in the thrombus decreases, but it is still From the Department of Haematology, University Hospital Utrecht, Utrecht, The Netherlands.Supported by the Dutch Heart Foundation (grant 86.044). Address for correspondence: Dr. Pim N.M. Tijburg, Department of Haematology, University Hospital Utrecht, Heidelberglaan 100, PO Box 85500, 3508 GA Utrecht, The Netherlands.Received November 16, 1989; revision accepted October 9, 1990. essential for stabilization of the mixed fibrin/ platelet thrombus. 8 -11 Studies of the fibrin content of thrombi have been notoriously hampered by the lack of methods for its quantification. The presence of fibrin is usually demonstrated by immunofluorescence with the use of radioisotopes or by morphological quantification.
12-15